Vanda Pharmaceuticals
Price & Volume
Stats
See moreOpen | $8.31 |
Previous Close | $8.28 |
Day Range | $8.18-$8.62 |
52W Range | $3.80-$9.60 |
Market Cap | $482.9M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $216.1M |
Revenue Growth (YoY) | 7.6% |
Gross Profit (12 Mos) | $203M |
Diluted EPS | -$3.74 |
News
See moreYahoo Finance • 10 hours ago
Vanda Pharmaceuticals price target raised to $17 from $14 at B. Riley
Yahoo Finance • yesterday
FDA Accepts Vanda's BLA For Imsidolimab In Generalized Pustular Psoriasis
Yahoo Finance • 23 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
Yahoo Finance • 2 months ago
Stocks Decline as Chip Makers and Data Storage Companies Fall
About
CEO | Dr. Mihael H. Polymeropoulos M.D. |
CFO | Mr. Kevin Patrick Moran |
Address | 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 533 |
